Pharmaceuticals & Biotech Healthcare Sector

Bausch + Lomb

Market Cap: US$4.2b

Operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally.

TransMedics Group

Market Cap: US$4.1b

A commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.

Vaxcyte

Market Cap: US$4.1b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Rhythm Pharmaceuticals

Market Cap: US$3.8b

A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.

Soleno Therapeutics

Market Cap: US$3.8b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

Krystal Biotech

Market Cap: US$3.8b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

ACADIA Pharmaceuticals

Market Cap: US$3.7b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Chartwell Retirement Residences

Market Cap: CA$5.2b

Chartwell is in the business of serving and caring for Canada's seniors, committed to its vision of Making People's Lives BETTER and to providing a happier, healthier, and more fulfilling life experience for its residents.

Perrigo

Market Cap: US$3.7b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Cytokinetics

Market Cap: US$3.7b

A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.

Avidity Biosciences

Market Cap: US$3.7b

A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).

PTC Therapeutics

Market Cap: US$3.6b

A biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally.

Sotera Health

Market Cap: US$3.6b

Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

Sarepta Therapeutics

Market Cap: US$3.6b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

Haemonetics

Market Cap: US$3.5b

A healthcare company, provides suite of medical products and solutions in the United States and internationally.

ICU Medical

Market Cap: US$3.5b

Develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide.

SpringWorks Therapeutics

Market Cap: US$3.5b

A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer.

1Life Healthcare

Market Cap: US$3.4b

1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand.

Ultragenyx Pharmaceutical

Market Cap: US$3.4b

A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.

Zai Lab

Market Cap: US$3.4b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

CRISPR Therapeutics

Market Cap: US$3.3b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

DENTSPLY SIRONA

Market Cap: US$3.3b

Develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide.

Arcellx

Market Cap: US$3.2b

Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.

PROCEPT BioRobotics

Market Cap: US$3.2b

A surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally.

Viking Therapeutics

Market Cap: US$3.2b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

Alvotech

Market Cap: US$3.2b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

Alignment Healthcare

Market Cap: US$3.1b

Operates a consumer-centric healthcare platform for seniors in the United States.

Amedisys

Market Cap: US$3.1b

Provides healthcare services in the United States.

Metsera

Market Cap: US$3.1b

A clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases.

Akero Therapeutics

Market Cap: US$3.1b

Engages in the development of treatments for patients with serious metabolic diseases in the United States.

Envista Holdings

Market Cap: US$3.1b

Develops, manufactures, markets, and sells dental products in the United States, China, and internationally.

Privia Health Group

Market Cap: US$3.1b

Operates as a national physician-enablement company in the United States.

Surgery Partners

Market Cap: US$3.0b

Owns and operates a network of surgical facilities and ancillary services in the United States.

Ansell

Market Cap: AU$4.7b

Designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America.

Catalyst Pharmaceuticals

Market Cap: US$3.0b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

Crinetics Pharmaceuticals

Market Cap: US$2.9b

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.